Enzyme replacement therapy in Fabry disease: towards a better understanding of the implications of antibody formation and dose - PubMed (original) (raw)
Comment
Enzyme replacement therapy in Fabry disease: towards a better understanding of the implications of antibody formation and dose
C E M Hollak et al. Mol Genet Metab. 2008 Dec.
No abstract available
Comment on
- Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.
Mehta A, Beck M, Kampmann C, Frustaci A, Germain DP, Pastores GM, Sunder-Plassmann G. Mehta A, et al. Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5. doi: 10.1016/j.ymgme.2008.07.002. Epub 2008 Aug 12. Mol Genet Metab. 2008. PMID: 18701330 No abstract available.
Similar articles
- Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
Brady RO, Tallman JF, Johnson WG, Gal AE, Leahy WR, Quirk JM, Dekaban AS. Brady RO, et al. N Engl J Med. 1973 Jul 5;289(1):9-14. doi: 10.1056/NEJM197307052890103. N Engl J Med. 1973. PMID: 4196713 No abstract available. - Enzyme replacement in genetic disease. Prospectus.
Krivit W, Bernlohr RW, Desnick RJ. Krivit W, et al. Birth Defects Orig Artic Ser. 1973 Mar;9(2):232-3. Birth Defects Orig Artic Ser. 1973. PMID: 4215476 Review. No abstract available. - Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
Rietra PJ, Molenaar JL, Hamers MN, Tager JM, Borst P. Rietra PJ, et al. Eur J Biochem. 1974 Jul 1;46(1):89-98. doi: 10.1111/j.1432-1033.1974.tb03600.x. Eur J Biochem. 1974. PMID: 4212108 No abstract available. - Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin.
Dawson G, Matalon R, Li YT. Dawson G, et al. Birth Defects Orig Artic Ser. 1973 Mar;9(2):97-101. Birth Defects Orig Artic Ser. 1973. PMID: 4215480 Review. No abstract available. - Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.
Ohashi T, Iizuka S, Ida H, Eto Y. Ohashi T, et al. Mol Genet Metab. 2008 Jul;94(3):313-8. doi: 10.1016/j.ymgme.2008.03.008. Epub 2008 May 5. Mol Genet Metab. 2008. PMID: 18456533
Cited by
- Enzyme replacement therapy for Fabry disease: some answers but more questions.
Alfadhel M, Sirrs S. Alfadhel M, et al. Ther Clin Risk Manag. 2011;7:69-82. doi: 10.2147/TCRM.S11987. Epub 2011 Feb 25. Ther Clin Risk Manag. 2011. PMID: 21445281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical